» Articles » PMID: 7727050

Drug Interactions with Antacids. Mechanisms and Clinical Significance

Overview
Journal Drug Saf
Specialties Pharmacology
Toxicology
Date 1994 Dec 1
PMID 7727050
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Concomitant use of antacid preparations with other medications is common. The potential for antacid-drug interactions is dependent upon the chemistry and physical properties of the antacid preparation. The intragastric release of free aluminum and magnesium ions has potent effects on gastrointestinal function and on drug pharmacokinetics. Antacid-drug interactions may occur secondary to changes in gastrointestinal motility or alterations in gastric and urinary pH. Direct adsorption also results in decreased drug bioavailability. Human drug interaction studies are usually performed with healthy volunteers; extrapolation of these results to clinical situations may not always be valid. However, the current literature would suggest that significant interactions with antacids do occur with certain members of the quinolone, nonsteroidal anti-inflammatory drug (NSAID) and cephalosporin classes of drugs. Notable interactions also occur with tetracycline, quinidine, ketoconazole and oral glucocorticoids. These interactions are particularly relevant in the patient with sepsis, cardiac disease or inflammatory syndromes.

Citing Articles

Concomitant prescription of oral fluoroquinolones with an antacid preparation.

Jhaj R, Sivagnanam G J Pharmacol Pharmacother. 2013; 4(2):140-2.

PMID: 23761711 PMC: 3669574. DOI: 10.4103/0976-500X.110898.


Safety of non-prescription medicines: knowledge and attitudes of Italian pharmacy customers.

Cuzzolin L, Benoni G Pharm World Sci. 2009; 32(1):97-102.

PMID: 19921545 DOI: 10.1007/s11096-009-9348-2.


pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model.

Zhou R, Moench P, Heran C, Lu X, Mathias N, Faria T Pharm Res. 2005; 22(2):188-92.

PMID: 15783065 DOI: 10.1007/s11095-004-1185-3.


Clinically significant drug interactions with cholinesterase inhibitors: a guide for neurologists.

Bentue-Ferrer D, Tribut O, Polard E, Allain H CNS Drugs. 2003; 17(13):947-63.

PMID: 14533945 DOI: 10.2165/00023210-200317130-00002.


Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects.

Lefevre G, Carpenter P, Souppart C, Schmidli H, McClean M, Stypinski D Br J Clin Pharmacol. 2002; 54(5):485-92.

PMID: 12445027 PMC: 1874456. DOI: 10.1046/j.1365-2125.2002.01696.x.


References
1.
Bergeron M . The pharmacokinetics and tissue penetration of the fluoroquinolones. Clin Invest Med. 1989; 12(1):20-7. View

2.
Day R, Lam S, Paull P, Wade D . Effect of food and various antacids on the absorption of tenoxicam. Br J Clin Pharmacol. 1987; 24(3):323-8. PMC: 1386253. DOI: 10.1111/j.1365-2125.1987.tb03176.x. View

3.
Preheim L, Cuevas T, Roccaforte J, Mellencamp M, Bittner M . Ciprofloxacin and antacids. Lancet. 1986; 2(8497):48. DOI: 10.1016/s0140-6736(86)92596-1. View

4.
Hansten P, Hayton W . Effect of antacid and ascorbic acid on serum salicylate concentration. J Clin Pharmacol. 1980; 20(5-6 Pt 1):326-31. DOI: 10.1177/009127008002000503. View

5.
Strom M . Antacid side-effects on bowel habits. Scand J Gastroenterol Suppl. 1982; 75:54-5. View